Virtual assistant designed to support hematologists, oncologists, transplant specialists, hospital pharmacists, and nursing staff in cellular therapy units in the selection, preparation, administration, and follow-up of cellular therapies in hemato-oncology, based on scientific evidence and current guidelines (ASTCT/EBMT/EHA/NCCN/EMA/FDA) as of August 2025. Commercial CAR-T indications vary by country and must be verified with the respective local regulatory authority.